Can infections trigger Erythema Nodosum Leprosum (ENL)-like reactions in susceptible individuals?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 31, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Infections as Triggers for Erythema Nodosum Leprosum (ENL) Reactions

Infections are well-documented triggers for Erythema Nodosum Leprosum (ENL) reactions in leprosy patients, with recent evidence specifically identifying Toxoplasma gondii coinfection as increasing ENL risk by nearly seven-fold. 1

Understanding ENL Reactions

ENL is a type 2 leprosy reaction characterized by:

  • Inflammatory skin nodules that can become necrotic
  • Systemic manifestations affecting multiple organs
  • Potential for nerve damage and disability
  • Occurrence during or after antibiotic treatment for leprosy

Epidemiology

  • Affects approximately 4.5% of multibacillary leprosy cases 2
  • Higher incidence (15.4%) in lepromatous leprosy patients 2
  • Multiple episodes occur in 39-77% of ENL patients 2
  • Can develop up to 5 years after completing multidrug therapy 2

Infection-Triggered ENL: Evidence and Mechanisms

Specific Infections as Triggers

  1. Toxoplasma gondii:

    • Recent 2024 research shows T. gondii coinfection increases ENL risk by 6.75 times (OR = 6.753; 95% CI: 1.050-72.85) 1
    • Associated with elevated IgE levels, which serve as a biomarker for ENL development 1

  2. Other infectious triggers:

    • Various bacterial and viral infections can precipitate ENL reactions 3
    • Pneumococcal infections are particularly concerning in leprosy patients due to immune dysregulation 4

Immunological Mechanisms

  • ENL is fundamentally an immune complex vasculitis 3
  • Infections can trigger ENL through:
    • Molecular mimicry between infectious agents and host antigens
    • Enhanced immune complex formation
    • Activation of complement pathways
    • Upregulation of inflammatory cytokines, particularly TNF-α 5

Clinical Presentation of Infection-Triggered ENL

Cutaneous Manifestations

  • Painful, tender erythematous nodules
  • Potential for ulceration and necrosis in severe cases 6
  • Distribution over trunk, extremities, and face

Systemic Manifestations

  • Fever
  • Arthralgia/arthritis
  • Lymphadenopathy
  • Neuritis with sensory and motor deficits
  • Multi-organ involvement in severe cases 6

Management Approach for Infection-Triggered ENL

Step 1: Identify and Treat the Triggering Infection

  • Comprehensive infectious disease workup
  • Appropriate antimicrobial therapy based on identified pathogen
  • Consider empiric coverage for common infections in endemic areas

Step 2: Control ENL Inflammation

  • First-line: Corticosteroids (prednisone 40-60mg daily with gradual taper)
  • Second-line: Thalidomide (if available and not contraindicated)
  • Alternative immunosuppressants: Clofazimine, methotrexate, cyclosporine

Step 3: Continue/Adjust Anti-Leprosy Treatment

  • Maintain multidrug therapy for leprosy
  • Consider temporary dose adjustments if drug hypersensitivity is suspected

Step 4: Prevention of Recurrent Infection-Triggered ENL

  • Pneumococcal vaccination is strongly recommended due to high infection risk in leprosy patients 4
  • Other recommended vaccinations based on regional epidemiology
  • Avoid potential triggering factors (stress, certain medications) 3

Special Considerations

Diagnostic Challenges

  • ENL triggered by infections may be misdiagnosed as cellulitis or other conditions 6
  • Bacteriological studies of ENL lesions are often negative 3
  • Diagnosis relies heavily on clinical examination and history of leprosy

Severe Cases

  • Necrotic ENL with systemic involvement has high mortality risk 6
  • Early recognition and aggressive management are critical
  • Consider anti-TNF-α therapy for refractory cases 5

Conclusion

When evaluating ENL reactions, clinicians should maintain a high index of suspicion for triggering infections, particularly in endemic areas for both leprosy and common coinfections like toxoplasmosis. Early identification and treatment of these infections, alongside appropriate management of the ENL reaction itself, are essential for preventing complications and reducing morbidity and mortality.

References

3
Research

[Study of erythema nodosum leprosum].

Annales de dermatologie et de venereologie, 1994

4
Guideline

Systemic Lupus Erythematosus Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Does integrating related medical topics improve learning outcomes?
Can people be allergic to naloxone (opioid antagonist)?
What is the appropriate management for soft tissue prominence in the cervix?
What is the best diagnostic test for a 64-year-old male with exertional dyspnea and a history of PTCA for AMI with LAD blockage, presenting with a holosystolic murmur and RV lift?
Can Bacterial Vaginosis (BV) cause cervicitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question